2 recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 2 | Recruiting 2 |
Follow Acute Lymphoblastic Leukemia ALL: new trials by email Literature Review of Acute Lymphoblastic Leukemia ALL trials Research Report on Acute Lymphoblastic Leukemia ALL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol Blinatumomab, Reinduction-2 omission, Chemo-light Maintenance 2 - Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic | Phase 2 / Phase 3 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 3000 | 2025-03-03 | 2025-08-26 |
| Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol Blinatumomab (Group A), Venetoclax (nonRand Group), Blinatumomab (Group B) - Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic | Phase 2 / Phase 3 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 1800 | 2025-01-03 | 2026-07-23 |
Burkitt Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)
DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, B-Cell (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2)
Dexamethasone (2) · Methotrexate (2) · Vincristine (2) · blinatumomab (2) · Asparaginase (1) · Cyclophosphamide (1) · Cytarabine (1) · Daunorubicin (1) · Prednisone (1) · venetoclax (1)
Institute of Hematology & Blood Diseases Hospital, China (2)
China (2) · Hong Kong (2)
Xiaofan Zhu, MD (2)